• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Venus Medtech

Keystone Heart inks distribution agreement with Vasorum

July 12, 2019 By Chris Newmarker

Keystone Heart has started distributing Ireland-based Vasorum’s Celt ACD vascular closure device in the U.S. and Europe, effective this month. Approved by FDA in 2016, the Celt ACT is a biocompatible implant meant to close femoral artery punctures taking place after catheterization. Health providers have implanted the CeltACT in more than 40,000 patients to date. […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Distribution, News Well Tagged With: Keystone Heart, Vasorum, Venus Medtech

Venus Medtech completes Keystone Heart merger

December 26, 2018 By Sarah Faulkner

Chinese transcatheter heart valve maker Venus Medtech said today that it closed its merger with Keystone Heart. Privately-held Keystone Heart sells TriGuard embolic protection devices that are designed to protect the brain during transcatheter aortic valve replacement and other cardiac procedures. Hoping for FDA approval in the third quarter of 2019, Keystone Heart is enrolling patients […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Mergers & Acquisitions, Vascular Tagged With: Keystone Heart, Venus Medtech

Venus Medtech to acquire Keystone Heart

September 25, 2018 By Fink Densford

Chinese heart valve maker Venus Medtech said today it inked a deal to acquire cerebral embolic protection device maker Keystone Heart for an undisclosed amount. Tampa, Fla.-based Keystone Heart developed and produces TriGuard embolic protection devices, which are designed to protect the brain from emboli during transcatheter aortic valve replacement and other heart procedures to reduce […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Mergers & Acquisitions, Vascular Tagged With: Keystone Heart, Venus Medtech

Venus Medtech launches Venus pulmonary valve implant

June 14, 2018 By Fink Densford

Chinese heart valve maker Venus Medtech said today it launched its Venus P-Valve self-expanding pulmonary valve implant in Canada, touting that the first procedures with the valve have been performed in the region. The Venus P-Valve was designed for percutaneous use in native right ventricular outflow tracts, the Hangzhou-baesd company said, and is intended for patients who […]

Filed Under: Business/Financial News, Cardiovascular, Replacement Heart Valves Tagged With: Venus Medtech

Venus Medtech inks exclusive TriGuard 3 deal with Keystone Heart

May 24, 2018 By Fink Densford

Chinese heart valve maker Venus Medtech said yesterday it inked a partnership deal with Keystone Heart through which Venus will gain exclusive rights to develop and sell a third-gen version of Keystone’s TriGuard 3 device in China and other Asian markets. The deal builds on a partnership between the two companies announced last March to promote Venus’ […]

Filed Under: Business/Financial News, Neurological, Replacement Heart Valves, Research & Development Tagged With: Keystone Heart, Venus Medtech

Venus Medtech wins backing from DCP Capital

May 16, 2018 By Fink Densford

Chinese heart valve maker Venus Medtech said yesterday it inked a definitive investment agreement with DCP Capital to support the upgrading and internationalization of its valve products. Through the deal, DCP Capital will also support clinical research into a new mitral and tricuspid valve disease treatment technology as the company looks to make a more solid entry into […]

Filed Under: Business/Financial News Tagged With: Venus Medtech

China’s Venus Medtech snaps up TAVR device developer InterValve

June 14, 2017 By Fink Densford

Chinese heart valve maker Venus Medtech said today it acquired U.S.-based transcatheter aortic valve replacement device developer InterValve for an undisclosed amount. Intervalve produces the V8 and TAV8 aortic valvuloplasty balloon catheters designed for performing percutaneous balloon angioplasty procedures and for pre and post-dilation during TAVR procedures. Venus said that the shape of the balloon helps […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Catheters, Mergers & Acquisitions Tagged With: InterValve Inc., Venus Medtech

Venus Medtech wins Chinese FDA approval for Venus A-valve TAVR

April 28, 2017 By Fink Densford

Chinese heart valve maker Venus Medtech said today it won China FDA approval for its Venus A-valve device, touting it as the 1st transcatheter aortic valve implantation device to win CFDA approval. The Venus A-valve device offers a less invasive treatment solution for inoperable and high-risk patients, providing a solution to patients in the region that previously was unavailable, […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Regulatory/Compliance, Replacement Heart Valves Tagged With: Venus Medtech

Keystone Heart, Venus Medtech ink Asian TAVR stroke partnership deal

March 2, 2017 By Fink Densford

Keystone Heart and Chinese heart valve maker Venus Medtech said today they inked a partnership deal covering China and other Asian markets. Through the deal, the companies will provide Venus Medtech’s transcatheter aortic valve replacement system along with Keystone’s TriGuard cerebral embolic protection device. TriGuard is a cerebral embolic protection device designed to reduce the amount of […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Replacement Heart Valves Tagged With: Keystone Heart, Venus Medtech

China’s Venus Medtech launches CE Mark trial for pulmonary valve replacement

September 19, 2016 By Fink Densford

Chinese heart valve maker Venus Medtech said today that it launched a clinical trial to support CE Mark approval in the European Union for its Venus P transcatheter pulmonary valve, designed to treat pulmonary regurgitation. The company said the 1st patient in the trial was implanted last week with the Venus P valve at London’s Evelina Children’s […]

Filed Under: Cardiovascular, Clinical Trials, Replacement Heart Valves Tagged With: Venus Medtech

Goldman Sachs gets in on Chinese cardiac valve maker Venus Medtech

March 25, 2016 By Brad Perriello

Chinese replacement heart valve maker Venus Medtech said today that it won a $37 million commitment from Goldman Sachs (NYSE:GS). Hangzhou-based Venus said it’s also won backing from Qiming Venture Partners, Sequoia Capital China, and Dinova Venture Capital. The company already has a transcatheter aortic valve replacement on the market in the People’s Republic and said a pulmonary […]

Filed Under: Funding Roundup, Replacement Heart Valves, Wall Street Beat Tagged With: Goldman Sachs, Venture Capital/Private Equity, Venus Medtech

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS